Results 221 to 230 of about 14,065,915 (293)
Abstract Early diagnosis of hepatocellular carcinoma (HCC) remains challenging because conventional serum biomarkers, especially alpha‐fetoprotein (AFP), show limited sensitivity for early‐stage disease. Recent progress in engineered molecular diagnostics provides new opportunities to improve HCC detection through integrated material, molecular, and ...
Jingzhi Xue +5 more
wiley +1 more source
The graphical abstract illustrates the interconnected relationship between food safety management, mycotoxin toxicity, and detoxification strategies, highlighting how preventive measures across the food chain can minimize mycotoxin contamination and reduce adverse health effects in humans/animals.
Chinaza Godswill Awuchi
wiley +1 more source
Baseline HDV-RNA Levels Could Stratify Clinical Risk Before, But Not After, Cirrhosis in Chronic Hepatitis D: A Multicentre European Study. [PDF]
Palom A +17 more
europepmc +1 more source
Chen, D. S.;Chen, H. H. M.;宋瑞樓;Kuo, Y. T.;Lo, K. J.;Shih, Y. T.;The Hepatitis Steering Committee;The Hepatitis Control Committee +1 more
core
Bringing attention to the moral dilemmas raised by xenotransplantation and the continuous creation of standardized frameworks for donor technology and biosafety risk management, with a focus on striking a balance between patient safety, medical innovation, and ethical obligation.
Sankhajyoti Saha +2 more
wiley +1 more source
The Complex Interplay of Hepatitis D in Patients with Hepatitis B: Letter to the Editor. [PDF]
Bagheri Lankarani K.
europepmc +1 more source
ABSTRACT Background Supportive care needs of patients receiving immune checkpoint inhibitors (ICIs) for head and neck squamous cell carcinoma (HNSCC) are ill‐defined. Hence, known treatment‐related adverse events (TRAEs) and health‐related quality of life (HRQoL) associated with ICI treatment for HNSCC were examined to inform future supportive care ...
N. D. O'Donnell +11 more
wiley +1 more source
Corrigendum to: "HBsAg protein composition and clinical outcomes in chronic hepatitis D and variations across HBeAg-negative chronic HBsAg carriers" [JHEP Reports 5 (2023) 100842]. [PDF]
Roade L +13 more
europepmc +1 more source
Updates on Recent Advancements in Hepatitis D Virus Treatment. [PDF]
Bardak AE +7 more
europepmc +1 more source
Burden and Clinical Impact of Hepatitis D Virus Co-Infection Among HBsAg-Positive Patients in Mauritania. [PDF]
Abdawa M +4 more
europepmc +1 more source

